Cargando…
Gonadotrophin-releasing hormone agonist-induced pituitary adenoma apoplexy and casual finding of a parathyroid carcinoma: A case report and review of literature
BACKGROUND: Pituitary apoplexy represents one of the most serious, life threatening endocrine emergencies that requires immediate management. Gonadotropin-releasing hormone agonist (GnRHa) can induce pituitary apoplexy in those patients who have insidious pituitary adenoma coincidentally. CASE SUMMA...
Autores principales: | Triviño, Vanessa, Fidalgo, Olga, Juane, Antía, Pombo, Jorge, Cordido, Fernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819301/ https://www.ncbi.nlm.nih.gov/pubmed/31667176 http://dx.doi.org/10.12998/wjcc.v7.i20.3259 |
Ejemplares similares
-
Gonadotropin-releasing hormone agonist-induced pituitary apoplexy
por: Keane, Fergus, et al.
Publicado: (2016) -
Gonadotropin-Releasing Hormone Agonist Induced Pituitary Apoplexy
por: Yu, Xiaoling, et al.
Publicado: (2021) -
Pituitary Apoplexy Secondary to Gonadotropin-Releasing Hormone Agonist for Breast Cancer
por: Mastandrea, Katherine, et al.
Publicado: (2023) -
Comparison of clinical outcomes between the depot gonadotrophin-releasing hormone agonist protocol and gonadotrophin-releasing hormone antagonist protocol in normal ovarian responders
por: Xia, Min, et al.
Publicado: (2021) -
Pituitary Adenoma Apoplexy: Review of Personal Series
por: Ricciuti, Riccardo, et al.
Publicado: (2018)